Hypertension in Advanced Chronic Kidney Disease: Saving the Kidneys or the Heart?

Ekamol Tantisattamo1, Elaine Ku2

  • 1Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine, Orange, CA; Excellent Center for Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Insights

Intensive blood pressure lowering benefits cardiovascular and kidney health, but evidence is limited in advanced chronic kidney disease (CKD). More research is needed for effective hypertension management in high-risk CKD patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Hypertension is a modifiable risk factor for cardiovascular disease (CVD) and chronic kidney disease (CKD) progression.
  • Intensive blood pressure lowering aims to mitigate cardiorenal risks, but trial data show inconsistencies in advanced kidney dysfunction.
  • Current hypertension management for CKD involves evolving therapeutic strategies.

Purpose of the Study:

  • To review trial-grade evidence on intensive blood pressure lowering for cardiorenal outcomes in hypertension.
  • To discuss the role of various antihypertensive agents in managing hypertension and CKD.
  • To highlight the need for further research in patients with advanced CKD.

Main Methods:

  • Overview of existing clinical trial data.
  • Focus on evidence for intensive blood pressure lowering and antihypertensive agents.
  • Analysis of cardiorenal outcomes in patients with varying degrees of kidney dysfunction.

Main Results:

  • Intensive blood pressure control shows benefits for cardiorenal outcomes.
  • Newer therapies like SGLT2 inhibitors and GLP-1 agonists offer proven benefits but have limited data in advanced CKD.
  • Renin-angiotensin system inhibitors remain a cornerstone, but newer agents expand treatment options.

Conclusions:

  • Hypertension management is crucial for mitigating cardiorenal risks in CKD patients.
  • While newer therapies show promise, their efficacy and safety in advanced CKD require further investigation.
  • High-risk patients with advanced CKD may need tailored antihypertensive strategies due to potential adverse effects.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...